Cytomegalovirus viremia, disease, and impact on relapse in T-cell replete peripheral blood haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide

Haematologica. 2016 Nov;101(11):e465-e468. doi: 10.3324/haematol.2016.149880. Epub 2016 Jul 21.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclophosphamide / therapeutic use
  • Cytomegalovirus
  • Cytomegalovirus Infections
  • Graft vs Host Disease / drug therapy
  • Graft vs Host Disease / prevention & control
  • Humans
  • Leukemia, Myeloid / complications
  • Leukemia, Myeloid / mortality
  • Leukemia, Myeloid / therapy*
  • Peripheral Blood Stem Cell Transplantation / adverse effects
  • Peripheral Blood Stem Cell Transplantation / methods*
  • Recurrence
  • T-Lymphocytes
  • Transplantation, Haploidentical / adverse effects
  • Transplantation, Haploidentical / methods*
  • Viremia

Substances

  • Cyclophosphamide